does tirzepatide help with alzheimer's Diabetes Dialogue: Semaglutide Falls Short Alzheimer Disease, Shows Promise in T1D How the weight loss drug

The Danish drugmaker, whose booming sales of GLP-1 diabetes and obesity drugs in recent years had turned it into Europes most valuable company, has lost nearly $100bn (75bn) in market value since cutting its full-year sales forecast last week, when its share price slid 30% in its worst week in more than two decades

The New York Times just published a piece about how GLP-1 medications are completely changing people's relationships with exercise

Not better or worse different

Neurobiol Aging (2009) 30:97386 10.1016/j.neurobiolaging.2007.09.009 [DOI] [PubMed] [Google Scholar] 139.Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, et al

The theory is that saturating hepatic methionine stores accelerates the initial metabolic shift